The impact of homologous recombination deficiency on the prognosis of epithelial ovarian cancer
Saved in:
Main Authors: | Haiqi Su, Yinan Wang, Xiaopei Chao, Huanwen Wu, Yan You, Shuru Zhao, Feiyue Wang, Bao Sun, Zhen Zhang, Ming Wu, Zicheng Zhao, Lei Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2025-01-01
|
Series: | Clinical and Translational Medicine |
Online Access: | https://doi.org/10.1002/ctm2.70143 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Whole exome sequencing-based homologous recombination deficiency test for epithelial ovarian cancer
by: Ying-Cheng Chiang, et al.
Published: (2025-01-01) -
Repression of PFKFB3 sensitizes ovarian cancer to PARP inhibitors by impairing homologous recombination repair
by: Yinan Xiao, et al.
Published: (2025-01-01) -
Homologous recombination deficiency test validation in patients with high-grade advanced ovarian cancer
by: Angelica Nogueira Rodrigues, et al.
Published: (2025-02-01) -
Low dose DNA methyltransferase inhibitors potentiate PARP inhibitors in homologous recombination repair deficient tumors
by: Romain Pacaud, et al.
Published: (2025-01-01) -
Enhanced radiosensitivity of head and neck cancer cells to proton therapy via hyperthermia-induced homologous recombination deficiency
by: Tim Heemskerk, et al.
Published: (2025-03-01)